Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus

Virology
Alexander A RumyantsevKonstantin V Pugachev

Abstract

A live chimeric vaccine virus against Japanese encephalitis (JE), ChimeriVax-JE, was used to define methods for optimal, random insertion of foreign immunologic determinants into flavivirus glycoproteins. The conserved M2e peptide of influenza A virus was randomly inserted into the yellow fever-specific NS1 glycoprotein of ChimeriVax-JE. A technique combining plaque purification with immunostaining yielded a recombinant virus that stably expressed M2e at NS1-236 site. The site was found permissive for other inserts. The insertion inhibited NS1 dimerization in vitro, which had no significant effect on virus replication in vitro and immunogenicity in vivo. Two different NS1-specific monoclonal antibodies and a polyclonal antibody efficiently recognized only the NS1 protein dimer, but not monomer. Adaptation of the virus to Vero cells resulted in two amino acid changes upstream from the insert which restored NS1 dimerization. Immunized mice developed high-titer M2e-specific antibodies predominantly of the IgG2A isotype indicative of a Th1-biased response.

References

Jun 5, 2003·International Journal for Parasitology·Konstantin V PugachevThomas P Monath
May 28, 2004·Virus Research·W FiersW Min Jou
Jan 5, 2005·Virology·Christopher T JonesRichard J Kuhn
Nov 2, 2005·The Journal of Experimental Medicine·Giovanna Barba-SpaethCharles M Rice
Jan 18, 2006·Virology·Peter J BredenbeekIgor S Lukashevich
Mar 1, 2006·Journal of Virological Methods·Andreas RangDetlev H Krüger
Apr 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Thomas P MonathPhilip Bedford
Nov 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kyung Min ChungMichael S Diamond
Dec 16, 2006·The Journal of General Virology·Dupeh R PalmerWellington Sun
Jan 4, 2007·Proceedings of the National Academy of Sciences of the United States of America·Huynh-Hoa BuiAlessandro Sette
Jun 20, 2008·Journal of Virology·Jason R WilsonFrank Scholle
Oct 11, 2008·Expert Review of Vaccines·Matthew R Olson, Steven M Varga
Apr 8, 2009·Expert Review of Vaccines·Michael SchotsaertXavier Saelens

❮ Previous
Next ❯

Citations

Mar 7, 2014·Proceedings of the National Academy of Sciences of the United States of America·Melissa A EdelingDaved H Fremont
Nov 26, 2010·Expert Review of Vaccines·Mohan Babu Appaiahgari, Sudhanshu Vrati
Feb 21, 2014·Human Vaccines & Immunotherapeutics·Myrna C BonaldoRicardo Galler
May 31, 2011·Vaccine·Alexander A RumyantsevKonstantin V Pugachev
Jul 27, 2017·Anais Da Academia Brasileira De Ciências·Telissa C KassarLaura H V G Gil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.